-60.1%
PINS vs GSK
+44.4%
-104.5%
-68.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | +0.5% | -0.4% | +0.1% |
| 7D | +1.0% | +1.1% | -0.1% | +0.8% |
| 30D | -12.0% | +6.3% | -18.3% | -12.8% |
| 3M | -17.9% | +1.8% | -19.7% | -18.2% |
| 6M | -1.0% | +1.7% | -2.7% | -1.5% |
| YTD | -26.0% | +6.5% | -32.6% | -28.0% |
| 1Y | -28.5% | +9.5% | -38.0% | -30.8% |
| 3Y | -39.2% | +65.3% | -104.5% | -48.9% |
| All | -60.1% | +44.4% | -104.5% | -66.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling